Skip to main content

Table 1 Baseline characteristics of the studied subjects (n = 106)

From: Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor

Variable

Value

Sex (male: %)

52.5

CML (%)

81.8

GIST (%)

18.2

Age (years)

40.2 ± 16.7

Weight (kg)

68.3 ± 14.4

Overweight (%)

47.7

IFG (%)

17.9

DM2 (%)

10.4

Creatinine (mg/dL)

0.93 (0.68–1.0)

ALT (U/L)

28.3 (14.2–31.0)

Mg (mg/dL)

2.1 ± 0.26

Glucose (mg/dL)

109 (86–104.5)

  1. Variables with normal distribution are expressed as mean ± s.d. Variables with non-parametric distribution are expressed as median (interquartile range). CML chronic myeloid leukemia, GIST gastrointestinal stromal tumor, IFG impaired fasting glucose, ALT alanine aminotransferase, Mg magnesium
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us